Milligrams vs Units: The GLP-1 Dosing Mistake That Sends People to the ER

Brand-name GLP-1 pens do one quietly important thing: they dose themselves. You dial a setting, click, and the pen delivers a fixed amount. You never touch the underlying arithmetic. The moment a GLP-1 comes instead as a vial of liquid plus a separate syringe — which is how much compounded semaglutide and tirzepatide is dispensed — that arithmetic lands back in the patient's hands, and it is the arithmetic where people get hurt.

The FDA has specifically warned about dosing errors and overdoses tied to compounded GLP-1s supplied this way. The core of it is a unit-conversion mistake. Here's what's actually going on.

Milligrams are the drug. Units are marks on the syringe. They are not interchangeable.

The dose your clinician prescribes is in milligrams (mg) — that's an amount of actual medication. But an insulin-style syringe isn't marked in milligrams. It's marked in units, which measure volume (a U-100 syringe treats 100 units as 1 milliliter). To turn a milligram dose into a number of units to draw, you have to know the concentration of that specific vial — how many milligrams are in each milliliter.

Change the concentration and the same milligram dose becomes a completely different number of units. That's the trap. A patient who learned "draw 20 units" on one vial, then refills from a vial at a different concentration and draws 20 units again, can deliver a wildly wrong dose without changing a single visible habit. The FDA's overdose reports include people who confused the units on the syringe with the milligrams in the prescription and drew ten times too much.

Why the pen version doesn't have this problem

This is the strongest single argument for the brand pen if arithmetic under stress isn't your thing. Ozempic, Wegovy, Mounjaro, and Zepbound pens are pre-concentrated and pre-metered. The dose selection is built in; there is no vial, no concentration to look up, no syringe to read. The failure mode above simply cannot happen, because you never convert anything.

Compounded vials are cheaper, which is much of why people use them. But the price difference partly reflects that the pen has engineered away a category of dangerous error, and the vial hands it back to you.

If you're comparing the two forms, the dose-by-dose brand schedules are laid out plainly for semaglutide and tirzepatide.

The rules that keep vial dosing safe

If you are using a vial-and-syringe GLP-1, a few habits prevent essentially all of the overdose reports:

1. Get the dose in both mg and units, in writing, for your specific vial. Your prescriber or pharmacist should tell you not just "2.5 mg" but "which is X units on your syringe, at this vial's concentration." If you only have the milligrams, you do not yet have enough information to draw a dose.
2. Re-confirm the units every time the vial's concentration changes. A new pharmacy, a new batch, a new strength — any of these can change the concentration and therefore the units. Never carry over the unit count from an old vial to a new one without checking.
3. Never "make up" a missed dose by doubling. For semaglutide, if you miss a weekly dose you can take it within about 5 days; past that, skip it and resume on schedule. For tirzepatide, the window is about 4 days. You do not stack two doses to catch up — that's a self-inflicted overdose.
4. Match the syringe to the plan. A U-100 insulin syringe reads in units; make sure the unit count you were given assumes the same syringe you're actually holding.

Titration exists for a reason — don't outrun it

Both molecules are started low and stepped up slowly on purpose. Semaglutide typically begins at 0.25 mg weekly and climbs over months; tirzepatide begins at 2.5 mg weekly and steps up similarly. The low starting doses aren't the effective weight-loss doses — they're there to let your gut adjust and to blunt the nausea, vomiting, and other GI effects that are worst when the dose jumps too fast.

The temptation with a vial is to titrate yourself faster than the schedule, because you can — nothing stops you from drawing more. Resist it. The escalation schedule is the difference between manageable side effects and a week of being unable to keep food down. It is a clinical schedule, not a suggestion, and the people who jump ahead are the ones who end up abandoning the drug over side effects they created.

The bottom line

The dangerous GLP-1 dosing errors almost all trace to one place: converting a milligram prescription into units on a syringe without knowing, or without rechecking, the vial's concentration. The pen removes that conversion entirely. The vial hands it to you and saves you money — a real trade, worth making only if you treat the mg-to-units conversion as something to confirm in writing every single time the vial changes.

If a dose ever feels wrong — if you drew far more units than usual for the same milligrams — stop, don't inject, and call the pharmacy before you do anything else. That two-minute call is the entire margin of safety.

Dosing schedules and missed-dose windows reflect the current FDA-approved prescribing information for the brand products as of July 2026. Compounded products are not FDA-approved and their concentrations vary by pharmacy — always confirm your specific vial with your prescriber.